Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Multicenter, Double-Blind, Placebo-Controlled, 18-Month Study of the Efficacy of Xaliproden in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type

NCT00103649 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00103649
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00103649 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Multicenter, Double-Blind, Placebo-Controlled, 18-Month Study of the Efficacy of Xaliproden in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type
Lead sponsor
Sanofi
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2003
Completion date
October 31, 2007
Enrollment
1,306 (actual)
Sites
121

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease